Immune cell protein identified as potential target for rare liver cancer treatment
Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease...
Fibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The disease...
ROCHESTER, Minn. — A new drug has been shown to increase healing and regeneration of the liver after major surgery,...